Halozyme Therapeutics
HALO
#2120
Rank
โ‚ฌ6.77 B
Marketcap
53,46ย โ‚ฌ
Share price
-0.44%
Change (1 day)
43.94%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ0.47 B

According to Halozyme Therapeutics's latest financial reports the company has โ‚ฌ0.47 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.30 B-10.13%
2022-12-31โ‚ฌ0.33 B-48.07%
2021-12-31โ‚ฌ0.65 B116.32%
2020-12-31โ‚ฌ0.30 B-19.76%
2019-12-31โ‚ฌ0.37 B21.23%
2018-12-31โ‚ฌ0.30 B-20.86%
2017-12-31โ‚ฌ0.39 B100.67%
2016-12-31โ‚ฌ0.19 B96.37%
2015-12-31โ‚ฌ99.23 M-10.93%
2014-12-31โ‚ฌ0.11 B115.26%
2013-12-31โ‚ฌ51.75 M-31.25%
2012-12-31โ‚ฌ75.28 M85.07%
2011-12-31โ‚ฌ40.67 M-35.18%
2010-12-31โ‚ฌ62.74 M33.16%
2009-12-31โ‚ฌ47.12 M4.35%
2008-12-31โ‚ฌ45.16 M-31.84%
2007-12-31โ‚ฌ66.25 M97.84%
2006-12-31โ‚ฌ33.48 M107.36%
2005-12-31โ‚ฌ16.15 M52.54%
2004-12-31โ‚ฌ10.58 M2526.31%
2003-12-31โ‚ฌ0.4 M333.34%
2002-12-31โ‚ฌ0.09 M214.46%
2001-12-31โ‚ฌ0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.22 B-53.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.03 B 535.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.89 B 296.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.40 B 1,242.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.57 B 1,276.88%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ22.98 B 4,715.42%๐Ÿ‡บ๐Ÿ‡ธ USA